Healthcare
AtriCure UK
United Kingdom
Company profile
About the company
AtriCure UK distributes medical devices used by clinicians treating atrial fibrillation and related cardiac conditions. Its portfolio supports surgical and minimally invasive ablation, left atrial appendage management and pain management after surgery, alongside professional education and product resources for healthcare teams. The UK entity serves hospitals and medical professionals without operating a domestic manufacturing site or dedicated office.
Public claim
What the listing records.
“AtriCure UK reports 2025 emissions of 104.23 tCO2e, 15% below 2024, and commits to net-zero emissions by 2050.”
Evidence note
The 31 March 2026 plan reports selected UK Scope 3 emissions, documents the annual reduction and states the entity's 2050 net-zero commitment.
Source type: Public report